Cargando…

536. Development of post acute sequelae of SARS-Cov-2 infection (long Covid) in outpatient receiving monoclonal antibodies

BACKGROUND: The development of post-acute sequelae of SARS-Cov-2 infection (long COVID), is a complex condition defined as a persistence of symptoms at least 3 months after initial infection. Although the etiology of long COVID is poorly understood, studies suggest it is related to immune dysregulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neto, Amelia, Kak, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677873/ http://dx.doi.org/10.1093/ofid/ofad500.605

Ejemplares similares

Age Differences in Becoming COVID Long-Haulers and in Post-Acute Sequelae of SARS-CoV-2
por: Wu, Qiao, et al.
Publicado: (2021)

280. Monoclonal Antibodies Against SARS-CoV-2 in Fragile Outpatients: Clinical and Laboratory Risk Factors and Protective Role of Vaccination
por: Cavasio, Rosario Alessandro, et al.
Publicado: (2022)

536. Clostridium difficile Colonization in the First Year of Life
por: Clayton, Jason A, et al.
Publicado: (2018)

90 Comparing Patient Demographics in Those Receiving Monoclonal Antibody Therapy For SARS-CoV-2 in the Emergency Department Versus Outpatient Infusion Centers: A Lesson in Health Care Access During a Global Pandemic
por: Drittel, D., et al.
Publicado: (2021)

536. Evaluation of the Clinical Utility of Universal Polymerase Chain Reaction Testing
por: Donkin, Joshua D, et al.
Publicado: (2022)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

Psychological and Cognitive Functioning Among Patients Receiving Outpatient Rehabilitation for Post-COVID Sequelae: An Observational Study
por: Abramoff, Benjamin A., et al.
Publicado: (2023)

Examining the Long-Term Sequelae of SARS-CoV2 Infection in Patients Seen in an Outpatient Psychiatric Department
por: Farooqi, Muhammad, et al.
Publicado: (2022)

1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection
por: Vikraman, Praveen Kumar, et al.
Publicado: (2022)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

392. The Impact of Therapeutic Interventions on Post-Acute Sequelae of SARS-CoV-2 (PASC) in COVID-19 Survivors: A Retrospective Analysis
por: Calderon, Andrea S, et al.
Publicado: (2023)

536. HIV Patients with COVID-19 in the Bronx: A Retrospective Cohort Study
por: Lee, Philip J, et al.
Publicado: (2020)

Orbital mucormycosis – Post SARS-CoV-2 sequelae
por: Mobeen, Hafsa, et al.
Publicado: (2021)

536. Challenges in Using MALDI-TOF Technology to Assess for KPC Resistance in Klebsiella pneumoniae isolates in America
por: Thompson, Michael Christopher, et al.
Publicado: (2019)

553. Outcomes in Patients Positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection After Treatment with Monoclonal Antibody Therapy (MAT) in the Outpatient Setting
por: Nichols, Courtney, et al.
Publicado: (2021)

360. A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies
por: Asiago, Josephat, et al.
Publicado: (2023)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022)

513. Use of Antimicrobial Stewardship Program in Operationalizing Monoclonal Antibody Therapy in SARS-CoV-2 Infection
por: Abrantes-Figueiredo, Jessica, et al.
Publicado: (2021)

479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients
por: Zeitler, Kristen, et al.
Publicado: (2021)

1348. Identification of GB-0669, a Novel S-2 Targeted Spike Monoclonal Antibody in Development for SARS-CoV-2 Prophylaxis
por: Borriello, Francesco, et al.
Publicado: (2023)

The optimal interval before receiving SARS-COV-2 vaccination for patients who have received Anti-CD 20 monoclonal antibodies
por: Liu, Kexin, et al.
Publicado: (2022)

Long-term neurological sequelae of SARS-CoV-2 infection
Publicado: (2022)

Long COVID: An inevitable sequela of SARS-CoV-2 infection
por: Lai, Chih-Cheng, et al.
Publicado: (2023)

Chronic SARS-CoV-2, a Cause of Post-acute COVID-19 Sequelae (Long-COVID)?
por: O’Donnell, Jake S., et al.
Publicado: (2021)

514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience
por: Belden, Katherine, et al.
Publicado: (2021)

532. Establishing a SARS-CoV-2 Monoclonal Antibody Infusion Clinic: Early Trends in Outcomes and Disparities
por: Hare, Allison J, et al.
Publicado: (2021)

Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
por: Assanto, Giovanni Manfredi, et al.
Publicado: (2022)

The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection
por: Moghimi, Narges, et al.
Publicado: (2021)

Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2
por: Mahmoud, Zainab, et al.
Publicado: (2022)

536. Clinical Outcomes of Hospitalized COVID-19 Patients Treated with Remdesivir-NEAT ID 909REM Study
por: Raffi, François, et al.
Publicado: (2021)

Long-term sequelae of SARS in children
por: Li, Albert M., et al.
Publicado: (2004)

Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
por: Gupta, Akshita, et al.
Publicado: (2023)

484. Clinical Description of SARS-CoV-2 Infection in Patients with Primary Antibody Deficiency Who Received Tixagevimab/Cilgavimab Prophylaxis
por: Lim, Sung Min, et al.
Publicado: (2023)

533. Protocol for and Efficacy of Monoclonal Antibody (mAb) Treatment of SARS-CoV-2 at a VA Medical Center
por: Nguyen, Phuong Khanh, et al.
Publicado: (2021)

Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL
por: Benjamini, Ohad, et al.
Publicado: (2022)

Delivering Monoclonal Antibody Infusions to Novel Outpatient Settings
por: Minnich, Amy, et al.
Publicado: (2022)

Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection
por: Llach, Cristian-Daniel, et al.
Publicado: (2021)

761 A Comparison of Outpatient Parenteral (OP) Antibiotic Therapy (AT) Outcomes: Physician Office and Home Based Therapy
por: O'neill, Donna, et al.
Publicado: (2014)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022)

A Post-Pandemic Enigma: The Cardiovascular Impact of Post-Acute Sequelae of SARS-CoV-2
por: Singh, Tamanna K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gheq9eg5s0q802re7856c1nkt4